Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 5.08 is in line with its 5-year average of 5.39, near the low end of its 5-year range (2.99–12.26).
As of the fiscal period ended Tuesday, June 30, 2026. 11.85% below its 12-month average of 5.76.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 5.08.
QUICK RATIO (ACID-TEST)
5.08
QUICK RATIO (ACID-TEST) AVG TTM
5.76
QUICK RATIO (ACID-TEST) AVG 3Y
5.09
QUICK RATIO (ACID-TEST) AVG 5Y
5.39
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-11.85%
CURRENT VS 3Y AVG
-0.28%
CURRENT VS 5Y AVG
-5.78%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 871 covered companies
CURRENT VS SECTOR MEDIAN
+51.50%
vs the sector median at left
Personalis, Inc.
Market Cap
$1.70B
Quick Ratio (Acid-Test)
5.08
TTM Avg
5.76
3Y Avg
5.09
5Y Avg
5.39
Market Cap
$1.70B
Quick Ratio (Acid-Test)
1.07
TTM Avg
0.89
3Y Avg
0.95
5Y Avg
0.97
Market Cap
$1.68B
Quick Ratio (Acid-Test)
9.93
TTM Avg
5.91
3Y Avg
4.26
5Y Avg
4.26
Market Cap
$1.72B
Quick Ratio (Acid-Test)
6.65
TTM Avg
5.42
3Y Avg
7.28
5Y Avg
7.47
Market Cap
$1.73B
Quick Ratio (Acid-Test)
1.02
TTM Avg
1.38
3Y Avg
1.55
5Y Avg
2.14
Market Cap
$1.74B
Quick Ratio (Acid-Test)
1.70
TTM Avg
1.79
3Y Avg
1.95
5Y Avg
2.14
Market Cap
$1.75B
Quick Ratio (Acid-Test)
1.78
TTM Avg
1.68
3Y Avg
1.66
5Y Avg
1.61
Market Cap
$1.76B
Quick Ratio (Acid-Test)
10.63
TTM Avg
5.62
3Y Avg
5.25
5Y Avg
6.00
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Personalis, Inc. (PSNL) | $1.70B | 5.08 | 5.76 | 5.09 | 5.39 |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.70B | 1.07 | 0.89 | 0.95 | 0.97 |
| Zenas BioPharma, Inc. (ZBIO)vs › | $1.68B | 9.93 | 5.91 | 4.26 | 4.26 |
| Intellia Therapeutics, Inc. (NTLA)vs › | $1.72B | 6.65 | 5.42 | 7.28 | 7.47 |
| Xeris Biopharma Holdings, Inc. (XERS)vs › | $1.73B | 1.02 | 1.38 | 1.55 | 2.14 |
| Novocure Ltd (NVCR)vs › | $1.74B | 2.70 | 2.06 | 4.13 | 5.41 |
| Alignment Healthcare, Inc. (ALHC)vs › | $1.74B | 1.70 | 1.79 | 1.95 | 2.14 |
| Surgery Partners, Inc. (SGRY)vs › | $1.75B | 1.78 | 1.68 | 1.66 | 1.61 |
| Absci Corporation (ABSI)vs › | $1.76B | 10.63 | 5.62 | 5.25 | 6.00 |
| Alphatec Holdings, Inc. (ATEC)vs › | $1.63B | 1.07 | 1.43 | 1.49 | 1.78 |
Quick Ratio
5.08
Excludes inventory
Current Ratio
5.28
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 5.08 |
| 2026-03-31 | 6.44 |
| 2025-12-31 | 6.61 |
| 2025-09-30 | 4.72 |
| 2025-06-30 | 5.95 |
| 2025-03-31 | 6.76 |
| 2024-12-31 | 6.39 |
| 2024-09-30 | 4.50 |
| 2024-06-30 | 3.18 |
| 2024-03-31 | 3.68 |
| 2023-12-31 | 2.99 |
| 2023-09-30 | 4.41 |
| 2023-06-30 | 5.46 |
| 2023-03-31 | 5.19 |
| 2022-12-31 | 5.83 |
| 2022-09-30 | 6.40 |
| 2022-06-30 | 6.11 |
| 2022-03-31 | 7.26 |
| 2021-12-31 | 10.03 |
| 2021-09-30 | 12.26 |
| 2021-06-30 | 10.27 |
| 2021-03-31 | 9.61 |
| 2020-12-31 | 5.37 |
| 2020-09-30 | 6.15 |
| 2020-06-30 | 2.72 |
| 2020-03-31 | 2.52 |
| 2019-12-31 | 2.77 |
| 2019-09-30 | 2.92 |
| 2019-06-30 | 3.10 |
| 2019-03-31 | 0.70 |
| 2018-12-31 | 0.47 |
| 2018-09-30 | 0.00 |
| 2018-06-30 | 0.00 |
| 2018-03-31 | 0.00 |
